House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Health Chair Brett Guthrie (R-KY) today announced a subcommittee legislative hearing to discuss the reauthorization of Food and Drug Administration animal drug and animal generic drug use free programs. 

“From pet owners, to farmers and poultry producers, Americans rely on pharmaceuticals and generic drugs to keep our animals healthy and happy. It’s crucial that we continue to modernize the FDA’s Center for Veterinary Medicine review process, so sponsors can continue to review bring safe and effective animal drugs to the market. We look forward to the work ahead on reauthorizing these critical user fee programs—as we’ve done in the past—before their September 30 expiration date.” 

Subcommittee on Health hearing titled “Reauthorization of the Animal Drug User Fee Programs.”

WHAT: A legislative hearing to discuss reauthorization of the FDA’s animal drug and animal generic drug user fee programs. 

DATE: Thursday, March 30, 2023 

TIME: 9:00 AM ET 

LOCATION: 2123 Rayburn House Office Building 

WITNESSES: Witnesses will be announced and are by invitation only. 

LEGISLATION UNDER CONSIDERATION: H.R. 1418, the Animal Drug User Fee Amendments of 2023, and H.R. 1683, the Generic Animal Drug Advancement Act. 

This notice is at the direction of the Chair. The hearing will be open to the public and press and will be live streamed online at https://energycommerce.house.gov/. If you have any questions concerning the hearing, please contact Jolie Brochin with the Committee staff at Jolie.Brochin@mail.house.gov. If you have any press-related questions, please contact Christopher Krepich at Christopher.Krepich@mail.house.gov. 

Original source can be found here.